Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qvar vs Flovent Diskus in Poorly Controlled Asthma
NCT00071552Phase 4Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2004
- Primary completion
- Jul 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of beclomethasone in asthma (2 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Change in post-inhalation percent-predicted FEF 25-75 (%) at 12 weeks. Started Jan 2004; status: terminated.
02
Drugs
beclomethasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00071552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071552.